Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 Ml
Abon Pharma Generic Sucralfate Receives Approval in the U.S
Enforcement Report - Week of October 25, 2023
VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1g/10mL Due to Microbial Contamination Identified as Bacillus Cereus
Enforcement Report - Week of September 20, 2023
Zydus Lifesciences Generic Sucralfate Receives Approval in the U.S.A
The central government on Tuesday added at least 34 drugs to the National List of Essential Medicines (NLEM) 2022 and dropped as many as 26 from the previous list. The new list contains a total 384 drugs in comparison to 376 in NLEM 2015. The NLEM 2022 comprises 384 drugs across 27 categories.
Mylan's Generic Sucralfate Receives Approval in the U.S.
Mylan's Generic Carafate, Sucralfate Receives Approval in the U.S.